Women's Health

Measurement of residual cancer burden served as both an accurate and consistent indicator of prognosis across breast cancer subtypes, according to an analysis of data from the randomized I-SPY2 trial published in JAMA Oncology.

Genetic testing for breast cancer has evolved substantially since its inception nearly 30 years ago, according to a speaker at Chemotherapy Foundation Symposium.

Women with cystic fibrosis have higher rates of pulmonary exacerbations compared with men, with differences appearing early in life, researchers reported at the virtual North American Cystic Fibrosis Conference.

Studies used to determine nutritional recommendations in the U.S. and Canada often lack women, including those who are pregnant, according to findings published in Science Advances.

Increased use of neoadjuvant chemotherapy appeared associated with improvements in short-term mortality without sacrificing long-term survival in ovarian cancer, according to a comparative effectiveness research study in JAMA Oncology.

Breast cancer screening rates declined within 32 community health centers serving lower-income populations during the COVID-19 pandemic, according to an American Cancer Society study published in Cancer.

Research suggests that the COVID-19 pandemic has disrupted breast cancer screening, diagnosis and treatment.

A considerable proportion of women who never received an HPV vaccine also never underwent cervical cancer screening or were not up to date on screening in 2019, according to findings published in JAMA Network Open.

The FDA granted fast track designation to nemvaleukin alfa as part of combination therapy for treatment of platinum-resistant ovarian cancer, according to the agent’s manufacturer.

Vision impairment may increase risk for future depressive symptoms among women during midlife, according to study results published in Menopause: The Journal of The North American Menopause Society.